Dietary Supplements Compendium 2019 Edition

Total Page:16

File Type:pdf, Size:1020Kb

Dietary Supplements Compendium 2019 Edition Products and Services New Dietary Supplements Reference Standards Below is a list of newly released Reference Standards. Herbal Medicines/ Botanical Dietary Supplements Negundoside Vitex negundo Leaf Dry Extract Baicalein Baicalein 7-O-Glucuronide Scutellaria Baicalensis Root Dry Extract Non-Botanicals Dietary Supplements Compendium 2019 Edition Conjugated Linoleic Acids – Triglycerides (100 mg) In response to customer feedback, coupled with the evolving information needs in our digital world, we have moved Docosahexaenoic Acid the USP Dietary Supplements Compendium (DSC) to an online platform for the 2019 edition. It continues to provide Eicosapentaenoic Acid in-depth, comprehensive information for all phases of development and manufacturing of quality dietary Omega-3 Free Fatty Acids supplements including quality control, quality assurance, and regulatory/compendial affairs. L-alpha- Glycerophosphorylethanolamine Some of the advantages that come with the new, online platform include: L-alpha- Glycerylphosphorylcholine More frequent updates to ensure that you have access to the most current information Customizable alerts to notify you when selected documents are changed beta-Glycerylphosphorylcholine Creatine An intuitive interface to quickly and easily navigate to the information you need Creatinine A customizable workspace with bookmarks, alerts and a viewing history to help streamline your Reference Standards in development: online experience Botanicals Convenient, anytime, anywhere access with most, commonly used browsers Bitter Orange Fruit In addition to selected new and revised monographs and General Chapters from the USP-NF and Flavonoid Dry Extract Coptis chinensis Rhizome Food Chemicals Codex issued over the last three years, the DSC 2019 features: Dry Extract 24 new General Chapters Coptisine Chloride 72 new dietary ingredient and dietary supplement monographs Epicatechin 27 sets of supplementary information for botanical and nonbotanical dietary supplements Guarana Seed Dry Extract 59 updated botanical HPTLC plates Procyanidin B2 Revised and updated dietary intake comparison tables Non-Botanicals Updated Dietary Supplement Verification Program manual Annatto Seed Tocotrienols View this page for more information or to subscribe to the 2019 online DSC. Extract Hydroxocobalamin Chloride Pyrroloquinoline quinone Upcoming Events and Meetings Monographs Activity on Probiotics Standards Open for Public Comment until September 30, The probiotics Expert Panel, which reports to the Non-Botanicals Dietary Supplement Expert Committee, published 2019 an article entitled “Improving end-user trust in the quality of commercial probiotic products” in Frontiers in The standards below were Microbiology in April. qNMR Summit Returns to Rockville published in PF 45(4) for public comment on July 1, 2019 and will accept public feedback until September 30, 2019. To comment, please visit: To comment, please visit: USP- NF Pharmacopeial Forum New Monographs/General Chapters Calcium Magnesium Citrate Please join us on October 2-3 as the Fifth International Quantitative NMR Summit is returning to USP in Rockville, D-chiro-Inositol MD, three years after the highly acclaimed inaugural 2016 event. This summit will be open to everyone so that you Fish Oil Omega-3 Acid can prepare for the paradigm-shifting update to compendial analysis. The summit will assemble the leading-edge Ethyl Esters Concentrate qNMR practitioners from around the world. In the tradition of the original event, this summit will be co-organized Pummelo Peel with Center for Natural Product Technologies (CeNaPT) from the University of Illinois in Chicago (UIC). Further Pummelo Peel Powder details will appear shortly at the USP Research and Innovation and the UIC/CeNaPT websites. A free NMR Pummelo Peel Flavonoids Validation Workshop will be held at the conclusion of the qNMR Summit on October 4, hosted by Steelyard Dry Extract Analytics. USP offers discounted pricing for governmental and academic attendees. Registration is now open. Register Today! Revised Monographs/General Chapters For questions related to the qNMR Summit, please contact Anton Bzhelyansky, [email protected]. Asian Ginseng Root and Rhizome Past Events Asian Ginseng Root and Rhizome Powder Asian Ginseng Root and CPhI-China and HNC 2019 Rhizome Dry Extract June 2019 | Shanghai, China American Ginseng Root and Rhizome In June 2019, staff from USP participated in the Convention on Pharmaceutical Ingredients (CPhI) in China exhibiting, speaking and hosting workshops, namely the Sino-US Symposium on Natural Health Products cohosted American Ginseng Root with ChP. Presentations and discussions centered on dietary supplement, health food and herbal medicine and Rhizome Powder regulations, standards and quality requirements. American Ginseng Root and Rhizome Dry Extract L-alpha- Glycerylphosphorylcholine Cod Liver Oil Cod Liver Oil Capsules Standards Open for Public Comment until November 30, 2019 The standards below will be published in PF 45(5) for public comment on September 1, 2019 and will accept public feedback until November 30, 2019. To comment, please visit: http://www.usp.org/usp- nf/pharmacopeial-forum New Monographs/General In this same month, USP also exhibited at the Healthplex Expo and Natural & Nutraceutical Products China 2019 Chapters (HNC) where staff members were able to meet with stakeholders in the nutraceutical, health food, and dietary supplement industry providing information and education on relevant standards and quality verification programs. Bifidobacterium bifidium Bifidobacterium longum 2019 Dietary Supplements Stakeholder Forum subsp longum May 15, 2019 | Rockville, MD Lactobacillus reuteri Water-Soluble Vitamins Over 200 stakeholders participated in the USP Dietary Supplements Stakeholder Forum at the USP Headquarters in Rockville, MD. Gisele Atkinson, B.S., and Jim Griffiths, Ph.D., Council for Responsible Nutrition chaired the Preparation meeting on behalf of the stakeholder panel. Participants representing manufacturers, trade associations, service providers, and other interested parties who work with dietary supplements shared perspectives and provided direct Revised Monographs/General feedback on priority standards issues. USP staff provided updates about recently proposed new monographs, Chapters revisions and omissions in Pharmacopeial Forum. Aztec Marigold Zeaxanthin Several high-impact topics including label claim and overages, standards for hemp, limits for pesticide residues, Extract testing for food allergens, and probiotics were discussed. Stakeholders provided feedback on the role USP public Lactobacillus rhamnosus standards in the light of the FDA initiatives to modernize the dietary supplement regulations. HN001 Stakeholders were also encouraged to apply as expert volunteers through USP’s Call for Candidates process for Standards Open for Public the 2020-2025 cycle of USP Council of Experts. Detailed notes from the meeting and the speaker presentations are available here. Comment until January 31, 2020 The standards below will be published in PF 45(6) for public comment on November 1, 2019 and will accept public feedback until January 31, 2020. To comment, please visit: http://www.usp.org/usp- nf/pharmacopeial-forum New Monographs/General Chapters Sour Jujube Seed Sour Jujube Seed Powder Sour Jujube Seed Dry Extract Cranberry Fruit Juice Dry Extract Cranberry Fruit Juice Concentrate Pomegranate Fruit Dry Image 1: Gabriel Giancaspro, Vice President, Science-DS & Herbal Medicines, presenting a gift to thank Gisele Atkinson, B.S., and Extract Jim Griffiths, Ph.D., with Council for Responsible Nutrition for their role as chairs of the 2019 DS Stakeholder Forum Broccoli Seed Dry Extract Revised Monographs/General Chapters Cranberry Liquid Preparation 2750 MANUFACTURING PRACTICES FOR DIETARY SUPPLEMENTS New Monographs under Development Botanicals Ajowan Fruit Ajowan Fruit Powder Ajowan Fruit Dry Extract Cranberry Fruit Dry Juice Feverfew Leaf Extract Red Clover Tablets Image 2: Panel discussion held during the DS Stakeholder Forum White Peony Root White Peony Root Powder Participation in the International Conference on the Science of Botanicals (ICSB) 2019 White Peony Root Dry April 8-11, 2019 | Oxford, MS Extract Gastrodia elata Rhizome Staff from the Dietary Supplements and Herbal Medicines at USP participated in the International Conference on Gastrodia elata Rhizome the Science of Botanicals (ICSB) held in Oxford, Mississippi. The discussion at the conference focused on 25th Anniversary of DSHEA (The Dietary Supplement Health and Education Act of 1994) including reviewing the history, Powder confronting the issues, and discussing future aspects Gastrodia elata Rhizome Dry extract Our staff participated in the following sessions: Saposhnikovia divaricata Root Expert Panel Saposhnikovia divaricata Root Powder Pharmacopeial Standards as Tools to Assure Botanical Quality Saposhnikovia divaricata Root Dry Extract Nandu Sarma, Ph.D. and Gabriel Giancaspro, PhD, US Pharmacopeia (USP) Ulrich Rose, PhD, European Pharmacopeia (EP) Non-Botanicals Roy Upton, RH, American Herbal Pharmacopeia (AHP) Astaxanthin ester capsules beta-hydroxy-beta- G N Singh, PhD, and Vivekanandan Kalaiselvan, PhD, Indian Pharmacopeia (IP) methylbutyric acid (HMB) Calcium 3-hydroxy-3- De-an Guo, PhD, member, Chinese Pharmacopeia (ChP) methylbutyrate Choline Citrate The global supply chain and the adoption of several botanicals that were traditionally used as medicine, foods or dietary supplements around the world
Recommended publications
  • Appendix a Common Abbreviations Used in Medication
    UNIVERSITY OF AMSTERDAM MASTERS THESIS Impact of Medication Grouping on Fall Risk Prediction in Elders: A Retrospective Analysis of MIMIC-III Critical Care Database Student: SRP Mentor: Noman Dormosh Dr. Martijn C. Schut Student No. 11412682 – SRP Tutor: Prof. dr. Ameen Abu-Hanna SRP Address: Amsterdam University Medical Center - Location AMC Department Medical Informatics Meibergdreef 9, 1105 AZ Amsterdam Practice teaching period: November 2018 - June 2019 A thesis submitted in fulfillment of the requirements for the degree of Master of Medical Informatics iii Abstract Background: Falls are the leading cause of injury in elderly patients. Risk factors for falls in- cluding among others history of falls, old age, and female gender. Research studies have also linked certain medications with an increased risk of fall in what is called fall-risk-increasing drugs (FRIDs), such as psychotropics and cardiovascular drugs. However, there is a lack of consistency in the definitions of FRIDs between the studies and many studies did not use any systematic classification for medications. Objective: The aim of this study was to investigate the effect of grouping medications at different levels of granularity of a medication classification system on the performance of fall risk prediction models. Methods: This is a retrospective analysis of the MIMIC-III cohort database. We created seven prediction models including demographic, comorbidity and medication variables. Medica- tions were grouped using the anatomical therapeutic chemical classification system (ATC) starting from the most specific scope of medications and moving up to the more generic groups: one model used individual medications (ATC level 5), four models used medication grouping at levels one, two, three and four of the ATC and one model did not include med- ications.
    [Show full text]
  • Chlorthalidone Is Superior to Potassium Citrate in Reducing Calcium Phosphate Stones and Increasing Bone Quality in Hypercalciuric Stone-Forming Rats
    BASIC RESEARCH www.jasn.org Chlorthalidone Is Superior to Potassium Citrate in Reducing Calcium Phosphate Stones and Increasing Bone Quality in Hypercalciuric Stone-Forming Rats Nancy S. Krieger,1 John R. Asplin,2 Ignacio Granja,2 Felix M. Ramos,1 Courtney Flotteron,1 Luojing Chen,1 Tong Tong Wu,3 Marc D. Grynpas,4 and David A. Bushinsky1 1Division of Nephrology, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York; 2Litholink Corporation, Laboratory Corporation of America Holdings, Chicago, Illinois; 3Department of Biostatistics and Computational Biology, University of Rochester School of Medicine, Rochester, New York; and 4Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada ABSTRACT Background The pathophysiology of genetic hypercalciuric stone-forming rats parallels that of human idiopathic hypercalciuria. In this model, all animals form calcium phosphate stones. We previously found that chlorthalidone, but not potassium citrate, decreased stone formation in these rats. Methods To test whether chlorthalidone and potassium citrate combined would reduce calcium phos- phate stone formation more than either medication alone, four groups of rats were fed a fixed amount of a normal calcium and phosphorus diet, supplemented with potassium chloride (as control), potassium citrate, chlorthalidone (with potassium chloride to equalize potassium intake), or potassium citrate plus chlorthalidone. We measured urine every 6 weeks and assessed stone formation and bone quality at 18 weeks. Results Potassium citrate reduced urine calcium compared with controls, chlorthalidone reduced it fur- ther, and potassium citrate plus chlorthalidone reduced it even more. Chlorthalidone increased urine citrate and potassium citrate increased it even more; the combination did not increase it further.
    [Show full text]
  • Increase of Urinary Putrescine In3,4-Benzopyrene Carcinogenesis
    [CANCER RESEARCH 38, 3509-3511, October 1978] 0008-5472/78/0038-0000$02.00 Increase of Urinary Putrescine in 3,4-Benzopyrene Carcinogenesis and Its Inhibition by Putrescine Keisuke Fujita,1 Toshiharu Nagatsu, Kan Shinpo, Kazuhiro Maruta, Hisahide Takahashi, and Atsushi Sekiya Institute for Comprehensive Medical Science ¡K.F., K. S., K. M.], Research Center for Laboratory Animals ¡H.T.¡,and Department of Pharmacology ¡A.S.¡, Fujita-Gakuen University School of Medicine, Toyoake, Aichi 470-11, Japan, and Laboratory of Cell Physiology, Department of Life Chemistry, Graduate School at Nagatsuta, Tokyo Institute of Technology, Yokohama 227, Japan ¡T.N.¡ ABSTRACT were included. Thirty female BALB/c mice, 19 to 20 weeks old and 25 to 30 g body weight, were given s.c. injections of A significant increase in putrescine was noted in the 2.52 mg of 3,4-benzopyrene in 0.5 ml of tricaprylin (Group urine of mice with experimental s.c. tumors induced by a B) or of 2.52 mg of 3,4-benzopyrene plus 10 mg of putres single injection of 3,4-benzopyrene solution (2.52 mg of cine dissolved in 0.5 ml of tricaprylin (Group B + P). As 3,4-benzopyrene in 0.5 ml of tricaprylin). When 10 mg of controls, 30 mice were given injections of 0.5 ml of tricapry putrescine were added to the 3,4-benzopyrene solution, lin (Group C), and 15 mice received 10 mg of putrescine in the development of tumors was completely inhibited and 0.5 ml of tricaprylin (Group P).
    [Show full text]
  • Dietary Supplements Compendium 2019 Edition
    Products and Services New Dietary Supplements Reference Standards Below is a list of newly released Reference Standards. Herbal Medicines/ Botanical Dietary Supplements Baicalein Baicalein 7-O-Glucuronide Chebulagic Acid Dietary Supplements Compendium 2019 Edition Coptis chinensis Rhizome Dry Extract In response to the customer feedback, coupled with evolving information needs, USP moved the Psoralen Dietary Supplements Compendium (DSC) to an online platform for the 2019 edition. DSC continues Scutellaria baicalensis Root Dry to provide in-depth, comprehensive information for all phases of development and manufacturing of Extract quality dietary supplements including quality control, quality assurance, and regulatory/compendial Terminalia chebula Fruit Dry affairs. Extract Guarana Seed Dry Extract Some of the advantages that come with the new online DSC edition include: Cullen Corylifolium Fruit Dry Extract More frequent updates to ensure access to the most current information Procyanidin B2 Customizable alerts to notify of changes to selected documents An intuitive interface to facilitate quick and easy navigation Non-Botanicals A customizable workspace with bookmarks, alerts and a viewing history beta-Glycerylphosphorylcholine Convenient, anytime, anywhere access with common browsers Conjugated Linoleic Acids – In addition to selected new and revised monographs and General Chapters from the USP-NF and Triglycerides Food Chemicals Codex issued since the previous 2015 edition, the DSC 2019 features: Creatine Docosahexaenoic Acid 24 new General Chapters Eicosapentaenoic Acid 72 new dietary ingredient and dietary supplement monographs L-alpha- 27 sets of supplementary information for botanical and nonbotanical dietary supplements Glycerophosphorylethanolamine 59 updated botanical HPTLC plates L-alpha- Revised and updated dietary intake comparison tables Glycerylphosphorylcholine Updated Dietary Supplement Verification Program manual Omega-3 Free Fatty Acids Pyrroloquinoline Quinone View this page for more information or to subscribe to the 2019 online DSC.
    [Show full text]
  • The Effect of Selected Herbal Extracts on Lactic Acid Bacteria Activity
    applied sciences Article The Effect of Selected Herbal Extracts on Lactic Acid Bacteria Activity Małgorzata Ziarno 1,* , Mariola Kozłowska 2 , Iwona Scibisz´ 3 , Mariusz Kowalczyk 4 , Sylwia Pawelec 4 , Anna Stochmal 4 and Bartłomiej Szleszy ´nski 5 1 Division of Milk Technology, Department of Food Technology and Assessment, Institute of Food Science, Warsaw University of Life Sciences–SGGW (WULS–SGGW), 02-787 Warsaw, Poland 2 Department of Chemistry, Institute of Food Science, Warsaw University of Life Sciences–SGGW (WULS–SGGW), 02-787 Warsaw, Poland; [email protected] 3 Division of Fruit, Vegetable and Cereal Technology, Department of Food Technology and Assessment, Institute of Food Science, Warsaw University of Life Sciences–SGGW (WULS–SGGW), 02-787 Warsaw, Poland; [email protected] 4 Department of Biochemistry and Crop Quality, Institute of Soil Science and Plant Cultivation, State Research Institute, 24-100 Puławy, Poland; [email protected] (M.K.); [email protected] (S.P.); [email protected] (A.S.) 5 Institute of Horticultural Sciences, Warsaw University of Life Sciences–SGGW (WULS–SGGW), 02-787 Warsaw, Poland; [email protected] * Correspondence: [email protected]; Tel.: +48-225-937-666 Abstract: This study aimed to investigate the effect of plant extracts (valerian Valeriana officinalis L., sage Salvia officinalis L., chamomile Matricaria chamomilla L., cistus Cistus L., linden blossom Tilia L., ribwort plantain Plantago lanceolata L., marshmallow Althaea L.) on the activity and growth of lactic acid bacteria (LAB) during the fermentation and passage of milk through a digestive system model. Citation: Ziarno, M.; Kozłowska, M.; The tested extracts were also characterized in terms of their content of polyphenolic compounds and Scibisz,´ I.; Kowalczyk, M.; Pawelec, S.; antioxidant activity.
    [Show full text]
  • Influence of Dietary Fiber Addition on the Properties of Probiotic Yogurt
    International Journal of Chemical Engineering and Applications, Vol. 5, No. 5, October 2014 Influence of Dietary Fiber Addition on the Properties of Probiotic Yogurt T. Ozcan and O. Kurtuldu low energy density, and should promote satiation and satiety, Abstract—In this study, the effects of using dietary fiber and play a role in the control of energy balance. These foods barley and oat β-glucan as a prebiotic on the viability of have the capacity of binding bile acids and metabolites of Bifidobacterium bifidum in probiotic yoghurt and properties of cholesterol that play an important role in digestion and yogurt during storage were investigated. The survival of B. absorption of lipids in the small intestine, lowering blood bifidum was within biotherapeutic level (> 7 log cfu/g) as a result of the prebiotic effect of barley and oat based β-glucan. cholesterol, regulating blood glucose levels for diabetes The addition of β-glucan to yogurt significantly affected management, producing short chain fatty acids and physicochemical properties including pH, titratable acidity promoting the growth of beneficial gut microflora (i.e. as a (LA %), whey seperation, color (L*, a*, b*) and sensorial prebiotic) [18]–[23]. Due to beneficiary health effects the properties of yogurts. In conclusion, β-glucan can be used on recommended daily intake of fiber is about 38 g for men and the development of cereal-based functional dairy products with sufficient viability and acceptable sensory characteristics. 25 g for women [24]. Fiber can be used for improvement of some functional Index Terms—Yoghurt, probiotic, dietary fiber, β-glucan. properties such as texture, water holding capacity, oil holding capacity, emulsification and/or gel formation, bulking agent in reduced-sugar applications, and shelf-life of I.
    [Show full text]
  • Probiotic Sufficiency™ Brochure
    Everybody - Everyday - For Life!TM Everybody Everyday For Life! ® RESEARCH INDICATES THAT: 1. Probiotic bacteria are ESSENTIAL for wellness and prevention. ® The human body contains 90% microorganisms Energy and only 10% human cells. Dietary sufficiency of healthy microorganisms (probiotics) is necessary for Vitality the proper function of the digestive and immune Strength systems and for overall wellness and prevention. Balance Natural Health 2. The Western diet is DANGEROUSLY DEFICIENT in Probiotic bacteria. Purity Research shows that we now consume one millionth of the healthy probiotic bacteria that we did before pesticides, herbicides, and industrial farming. We also kill many of our probiotic bacteria with poor nutrition, prescription drugs, and stress. This PROBIOTIC deficiency of healthy probiotic bacteria is implicated TM as a casual factor in lack of health and vitality and an alarming number of preventable illnesses from SUFFICIENCY infancy to old age. The Innate Human Probiotic Formula 3. The only way to obtain sufficient amounts of Everybody - Everyday - For Life!™ ® healthy probiotic bacteria is through daily How to consume Innate Choice PROBIOTIC SUFFICIENCY™ SUPPLEMENTATION. Please visit www.innatechoice.com for The dietary sources of probiotic bacteria are virtually The World’s Premier Multi-Strain a complete list of references supporting the A Dietary Supplement to Promote unavailable in industrialized society. Our fruits Probiotic Supplement importance of daily probiotic supplementation for Healthy Intestinal Flora and vegetables are sprayed with pesticides, much Adults should consume 2 capsules per day with a meal wellness and prevention. of our food is pasteurized or irradiated, and we do containing raw fruit or vegetables. not consume sufficient amounts of fresh, raw, local foods.
    [Show full text]
  • Folic Acid, Pyridoxine, and Cyanocobalamin Combination
    ORIGINAL INVESTIGATION Folic Acid, Pyridoxine, and Cyanocobalamin Combination Treatment and Age-Related Macular Degeneration in Women The Women’s Antioxidant and Folic Acid Cardiovascular Study William G. Christen, ScD; Robert J. Glynn, ScD; Emily Y. Chew, MD; Christine M. Albert, MD; JoAnn E. Manson, MD Background: Observational epidemiologic studies indi- and visually significant AMD, defined as confirmed in- cate a direct association between homocysteine concentra- cident AMD with visual acuity of 20/30 or worse attrib- tion in the blood and the risk of age-related macular degen- utable to this condition. eration (AMD), but randomized trial data to examine the effect of therapy to lower homocysteine levels in AMD are Results:Afteranaverageof7.3yearsoftreatmentandfollow- lacking. Our objective was to examine the incidence of AMD up, there were 55 cases of AMD in the combination treat- in a trial of combined folic acid, pyridoxine hydrochloride ment group and 82 in the placebo group (relative risk, 0.66; (vitamin B6), and cyanocobalamin (vitamin B12) therapy. 95% confidence interval, 0.47-0.93 [P=.02]). For visually significant AMD, there were 26 cases in the combination Methods: We conducted a randomized, double-blind, treatment group and 44 in the placebo group (relative risk, placebo-controlled trial including 5442 female health care 0.59; 95% confidence interval, 0.36-0.95 [P=.03]). professionals 40 years or older with preexisting cardio- vascular disease or 3 or more cardiovascular disease risk Conclusions: These randomized trial data from a large factors. A total of 5205 of these women did not have a cohort of women at high risk of cardiovascular disease diagnosis of AMD at baseline and were included in this indicate that daily supplementation with folic acid, pyri- analysis.
    [Show full text]
  • The Effects of New Zealand Grown Ginseng Fractions on Cytokine Production from Human Monocytic THP-1 Cells
    molecules Article The Effects of New Zealand Grown Ginseng Fractions on Cytokine Production from Human Monocytic THP-1 Cells Wei Chen 1,2,3 , Prabhu Balan 2,3 and David G. Popovich 1,* 1 School of Food and Advanced Technology, Massey University, Palmerston North 4442, New Zealand; [email protected] 2 Riddet Institute, Massey University, Palmerston North 4442, New Zealand; [email protected] 3 Alpha-Massey Natural Nutraceutical Research Centre, Massey University, Palmerston North 4442, New Zealand * Correspondence: [email protected]; Tel.: +64-63569099 Abstract: Pro-inflammatory cytokines and anti-inflammatory cytokines are important mediators that regulate the inflammatory response in inflammation-related diseases. The aim of this study is to eval- uate different New Zealand (NZ)-grown ginseng fractions on the productions of pro-inflammatory and anti-inflammatory cytokines in human monocytic THP-1 cells. Four NZ-grown ginseng fractions, including total ginseng extract (TGE), non-ginsenoside fraction extract (NGE), high-polar ginsenoside fraction extract (HPG), and less-polar ginsenoside fraction extract (LPG), were prepared and the gin- senoside compositions of extracts were analyzed by HPLC using 19 ginsenoside reference standards. The THP-1 cells were pre-treated with different concentrations of TGE, NGE, HPG, and LPG, and were then stimulated with lipopolysaccharide (LPS). The levels of pro-inflammatory cytokines, including tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), interleukin-6 (IL-6), interleukin-8 (IL-8), and anti-inflammatory cytokines, such as interleukin-10 (IL-10), and transforming growth factor beta-1 (TGF-β1), were determined by enzyme-linked immunosorbent assay (ELISA).
    [Show full text]
  • Enzymatic Assay of L-METHIONINE GAMMA-LYASE (EC 4.4.1.11)
    Enzymatic Assay of L-METHIONINE GAMMA-LYASE (EC 4.4.1.11) PRINCIPLE: L-Methionine Gamma-Lyase L-Methionine > Methanethiol + 2-Ketobutyrate + NH3 2-Ketobutyrate + MBTH > Azine Derivative Abbreviation used: MBTH = 3-Methyl-2-Benzothiazolinone CONDITIONS: T = 37°C, pH = 8.0, A320nm, Light path = 1 cm METHOD: Stopped Spectrophotometric Rate Determination REAGENTS: A. 100 mM Potassium Phosphate Buffer with 25 mM L-Methionine and 0.01 mM Pyridoxal 5-Phosphate, pH 8.0 at 37°C1 (Prepare 100 ml in deionized water using Potassium Phosphate, Monobasic, Anhydrous, Sigma Prod. No. P-5379, L-Methionine, Sigma Prod. No. M-9625, and Pyridoxal 5-Phosphate, Sigma Prod. No. P-9255. Adjust to pH 8.0 at 37°C with 5 M KOH.) B. 50% (w/v) Trichloroacetic Acid Solution (TCA) (Prepare 5 ml in deionized water using Trichloroacetic Acid, 6.1 N Solution, approximately 100% (w/v), Sigma Stock No. 490-10.) C. 1 M Sodium Acetate Buffer, pH 5.0 at 37°C (NaOAC) (Prepare 100 ml in deionized water using Sodium Acetate, Trihydrate, Sigma Prod. No. S-8625. Adjust to pH 5.0 at 37°C with 5 M HCl.) D. 0.1% (w/v) 3-Methyl-2-Benzothiazolinone Hydrazone (MBTH) (Prepare 10 ml in deionized water using 3-Methyl-2-Benzothiazolinone Hydrazone, Hydrochloride Hydrate, Sigma Prod. No. M-8006.) SSMETH01 Page 1 of 4 07/29/98 Enzymatic Assay of L-METHIONINE GAMMA-LYASE (EC 4.4.1.11) REAGENTS: E. 100 mM Potassium Phosphate Buffer with 1 mM Ethylenediaminetetraacetic Acid, 0.01% (v/v) 2-Mercaptoethanol and 0.02 mM Pyridoxal 5-Phosphate, pH 7.2 at 37°C (Enzyme Diluent)1 (Prepare 10 ml in deionized water using Potassium Phosphate, Monobasic, Anhydrous, Sigma Prod.
    [Show full text]
  • Lyxumia Subcutaneous Injection 300 Μg [Non-Proprietary Name] Lixisenatide (JAN*) [Name of Applicant] Sanofi K.K
    Report on the Deliberation Results May 31, 2013 Evaluation and Licensing Division, Pharmaceutical and Food Safety Bureau Ministry of Health, Labour and Welfare [Brand name] Lyxumia Subcutaneous Injection 300 μg [Non-proprietary name] Lixisenatide (JAN*) [Name of applicant] Sanofi K.K. [Date of application] June 11, 2012 [Results of deliberation] In the meeting held on May 24, 2013, the First Committee on New Drugs concluded that the product may be approved and that this result should be reported to the Pharmaceutical Affairs Department of the Pharmaceutical Affairs and Food Sanitation Council. The re-examination period for the product is 8 years, and the drug substance and the drug product are both classified as powerful drugs and the product is not classified as a biological product or a specified biological product. The proposed Japanese brand name should be changed for ensuring medical safety. *Japanese Accepted Name (modified INN) This English version of the Japanese review report is intended to be a reference material to provide convenience for users. In the event of inconsistency between the Japanese original and this English translation, the former shall prevail. The PMDA will not be responsible for any consequence resulting from the use of this English version. Review Report May 7, 2013 Pharmaceuticals and Medical Devices Agency The results of a regulatory review conducted by the Pharmaceuticals and Medical Devices Agency on the following pharmaceutical product submitted for registration are as follows. [Brand name] Lyxumia Subcutaneous
    [Show full text]
  • Guidelines on Food Fortification with Micronutrients
    GUIDELINES ON FOOD FORTIFICATION FORTIFICATION FOOD ON GUIDELINES Interest in micronutrient malnutrition has increased greatly over the last few MICRONUTRIENTS WITH years. One of the main reasons is the realization that micronutrient malnutrition contributes substantially to the global burden of disease. Furthermore, although micronutrient malnutrition is more frequent and severe in the developing world and among disadvantaged populations, it also represents a public health problem in some industrialized countries. Measures to correct micronutrient deficiencies aim at ensuring consumption of a balanced diet that is adequate in every nutrient. Unfortunately, this is far from being achieved everywhere since it requires universal access to adequate food and appropriate dietary habits. Food fortification has the dual advantage of being able to deliver nutrients to large segments of the population without requiring radical changes in food consumption patterns. Drawing on several recent high quality publications and programme experience on the subject, information on food fortification has been critically analysed and then translated into scientifically sound guidelines for application in the field. The main purpose of these guidelines is to assist countries in the design and implementation of appropriate food fortification programmes. They are intended to be a resource for governments and agencies that are currently implementing or considering food fortification, and a source of information for scientists, technologists and the food industry. The guidelines are written from a nutrition and public health perspective, to provide practical guidance on how food fortification should be implemented, monitored and evaluated. They are primarily intended for nutrition-related public health programme managers, but should also be useful to all those working to control micronutrient malnutrition, including the food industry.
    [Show full text]